Stock Events

Stock Events

CERo Therapeutics (CERO) Q1 2026 Earnings

25FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-124.26

-83.09

-41.92

-0.75

Details

Expected EPS

-0.75

Actual EPS

-0.75

Surprise EPS

0

Surprise Percent

+0%

Description

CERo Therapeutics (CERO) has reported earnings of -0.75 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.